Oragenics, Inc. (OGEN)
-0.010 (-0.94%)
Apr 23, 2024, 12:10 PM EDT - Market open

Oragenics Statistics

Total Valuation

Oragenics has a market cap or net worth of $4.70 million. The enterprise value is $1.59 million.

Market Cap 4.70M
Enterprise Value 1.59M

Important Dates

The next estimated earnings date is Friday, May 10, 2024, after market close.

Earnings Date May 10, 2024
Ex-Dividend Date n/a

Share Statistics

Oragenics has 4.48 million shares outstanding. The number of shares has increased by 11.97% in one year.

Shares Outstanding 4.48M
Shares Change (YoY) +11.97%
Shares Change (QoQ) +9.92%
Owned by Insiders (%) 23.23%
Owned by Institutions (%) 7.38%
Float 3.95M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 126.14
Forward PS n/a
PB Ratio 1.50
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 42.19
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.15, with a Debt / Equity ratio of 0.10.

Current Ratio 2.15
Quick Ratio n/a
Debt / Equity 0.10
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -674.22

Financial Efficiency

Return on equity (ROE) is -304.10% and return on invested capital (ROIC) is -598.88%.

Return on Equity (ROE) -304.10%
Return on Assets (ROA) -246.90%
Return on Capital (ROIC) -598.88%
Revenue Per Employee $7,531
Profits Per Employee -$4.13M
Employee Count 5
Asset Turnover 0.01
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -65.25% in the last 52 weeks. The beta is 0.32, so Oragenics's price volatility has been lower than the market average.

Beta (1Y) 0.32
52-Week Price Change -65.25%
50-Day Moving Average 1.84
200-Day Moving Average 3.34
Relative Strength Index (RSI) 29.97
Average Volume (30 Days) 99,161

Short Selling Information

The latest short interest is 41,260, so 0.92% of the outstanding shares have been sold short.

Short Interest 41,260
Short Previous Month 297,346
Short % of Shares Out 0.92%
Short % of Float 1.04%
Short Ratio (days to cover) 0.27

Income Statement

In the last 12 months, Oragenics had revenue of $37,653 and -$20.66 million in losses. Loss per share was -$9.18.

Revenue 37,653
Gross Profit 37,653
Operating Income -20.90M
Pretax Income -20.66M
Net Income -20.66M
EBITDA -20.60M
EBIT -20.63M
Loss Per Share -$9.18
Full Income Statement

Balance Sheet

The company has $3.48 million in cash and $322,514 in debt, giving a net cash position of $3.16 million or $0.71 per share.

Cash & Cash Equivalents 3.48M
Total Debt 322,514
Net Cash 3.16M
Net Cash Per Share $0.71
Equity / Book Value 3.17M
Book Value Per Share 0.71
Working Capital 2.07M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.29 million and capital expenditures $63,716, giving a free cash flow of -$7.23 million.

Operating Cash Flow -7.29M
Capital Expenditures 63,716
Free Cash Flow -7.23M
FCF Per Share -$3.21
Full Cash Flow Statement


Gross margin is 100.00%, with operating and profit margins of -55,519.89% and -54,858.14%.

Gross Margin 100.00%
Operating Margin -55,519.89%
Pretax Margin -54,858.14%
Profit Margin -54,858.14%
EBITDA Margin -54,704.15%
EBIT Margin -54,776.90%
FCF Margin -19,194.13%

Dividends & Yields

Oragenics does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -11.97%
Shareholder Yield -11.97%
Earnings Yield -434.90%
FCF Yield -152.17%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on January 23, 2023. It was a reverse split with a ratio of 1:60.

Last Split Date Jan 23, 2023
Split Type Reverse
Split Ratio 1:60


Oragenics has an Altman Z-Score of -69.75 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -69.75
Piotroski F-Score 1